Medical Marketing Group agrees to settle preliminary injunction request brought by The Vanderveer Group. Under Aug. 23 agreement, MMG will "cease copying TVG materials," "return all TVG materials," "alert the marketplace by sending a return receipt letter," and "refrain from accepting business based on proposals that contained plagarized materials," TVG says. TVG "will now concentrate on the preparation for the trial on the full eight counts it has filed against MMG" ("The Pink Sheet" Aug. 9, T&G-6).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth